Literature DB >> 6922691

In vitro activity of antibiotics commonly used in the treatment of otitis media against Streptococcus pneumoniae isolates with different susceptibilities to penicillin.

M M Tarpay, D F Welch, H Salari, M I Marks.   

Abstract

Susceptibilities of 82 clinical isolates of Streptococcus pneumoniae, including 25 from the middle-ear fluid, were evaluated against antibiotics commonly used in the treatment of acute otitis media. Potentially significant resistance occurred in 6% of the isolates to erythromycin and an erythromycin-sulfisoxazole combination. The combination of trimethoprim and sulfamethoxazole was synergistic for 95% of the isolates. Only 2.5% of all of the isolates were resistant to both erythromycin-sulfisoxazole and trimethoprim-sulfamethoxazole. The presently used drug regimens should be effective against the majority of S. pneumoniae isolates in otitis media.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6922691      PMCID: PMC183689          DOI: 10.1128/AAC.22.1.145

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  11 in total

1.  Antagonists of nucleic acid derivatives. VIII. Synergism in combinations of biochemically related antimetabolites.

Authors:  G B ELION; S SINGER; G H HITCHINGS
Journal:  J Biol Chem       Date:  1954-06       Impact factor: 5.157

2.  Streptococcus pneumoniae resistant to erythromycin and clindamycin.

Authors:  L A Champion; E R Wald; R E Luddy; A D Schwartz
Journal:  J Pediatr       Date:  1978-03       Impact factor: 4.406

3.  Otitis media of infancy and early childhood. A double-blind study of four treatment regimens.

Authors:  J E Howard; J D Nelson; J Clahsen; L H Jackson
Journal:  Am J Dis Child       Date:  1976-09

4.  The increasing incidence of Ampicillin-resistant Haemophilus influenzae. A cause of otitis media.

Authors:  R Schwartz; W Rodriguez; W Khan; S Ross
Journal:  JAMA       Date:  1978-01-23       Impact factor: 56.272

5.  Erythromycin concentrations in middle ear exudates.

Authors:  J W Bass; R W Steele; R A Wiebe; E P Dierdorff
Journal:  Pediatrics       Date:  1971-09       Impact factor: 7.124

6.  Bacteriology of acute otitis media unresponsive to initial antimicrobial therapy.

Authors:  D W Teele; S I Pelton; J O Klein
Journal:  J Pediatr       Date:  1981-04       Impact factor: 4.406

7.  Penetration characteristics of trimethoprim-sulfamethoxazole in middle ear fluid of patients with chronic serous otitis media.

Authors:  J J Klimek; T R Bates; C Nightingale; W B Lehmann; J A Ziemniak; R Quintiliani
Journal:  J Pediatr       Date:  1980-06       Impact factor: 4.406

8.  Persistent purulent otitis media.

Authors:  R H Schwartz; W J Rodriguez; W N Khan
Journal:  Clin Pediatr (Phila)       Date:  1981-07       Impact factor: 1.168

9.  Trimethoprim-sulfamethoxazole compared with ampicillin in the treatment of acute otitis media.

Authors:  P A Shurin; S I Pelton; A Donner; J Finkelstein; J O Klein
Journal:  J Pediatr       Date:  1980-06       Impact factor: 4.406

10.  Susceptibility of group A beta-hemolytic Streptococcus isolates to penicillin and erythromycin.

Authors:  G R Istre; D F Welch; M I Marks; N Moyer
Journal:  Antimicrob Agents Chemother       Date:  1981-08       Impact factor: 5.191

View more
  8 in total

Review 1.  World-wide development of antibiotic resistance in pneumococci.

Authors:  P C Appelbaum
Journal:  Eur J Clin Microbiol       Date:  1987-08       Impact factor: 3.267

2.  Interpretive criteria and quality control parameters for testing of susceptibilities of Haemophilus influenzae and Streptococcus pneumoniae to trimethoprim and trimethoprim-sulfamethoxazole. The Antimicrobial Susceptibility Testing OC Group.

Authors:  P C Fuchs; A L Barry; S D Brown
Journal:  J Clin Microbiol       Date:  1997-01       Impact factor: 5.948

3.  In vitro activities of five fluoroquinolone compounds against strains of Streptococcus pneumoniae with resistance to other antimicrobial agents.

Authors:  A L Barry; P C Fuchs; S D Brown
Journal:  Antimicrob Agents Chemother       Date:  1996-10       Impact factor: 5.191

4.  Cotrimoxazole resistance in pneumococci.

Authors:  J Linares; J L Pérez; J Garau; R Martin
Journal:  Eur J Clin Microbiol       Date:  1983-10       Impact factor: 3.267

Review 5.  Antimicrobial resistance in Streptococcus pneumoniae: a growing universal concern.

Authors:  S S Hussein; A M Shibl; H M Bahakem; M M Sofan
Journal:  J Natl Med Assoc       Date:  1989-09       Impact factor: 1.798

6.  Antimicrobial resistance among respiratory isolates of Haemophilus influenzae, Moraxella catarrhalis, and Streptococcus pneumoniae in the United States.

Authors:  J H Jorgensen; G V Doern; L A Maher; A W Howell; J S Redding
Journal:  Antimicrob Agents Chemother       Date:  1990-11       Impact factor: 5.191

Review 7.  Pneumococcal resistance to antibiotics.

Authors:  K P Klugman
Journal:  Clin Microbiol Rev       Date:  1990-04       Impact factor: 26.132

Review 8.  Infections due to antibiotic-resistant gram-positive cocci.

Authors:  G M Caputo; M Singer; S White; M R Weitekamp
Journal:  J Gen Intern Med       Date:  1993-11       Impact factor: 5.128

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.